Home › Major Depressive Disorder
Pag-aaral pangklinika para sa Major Depressive Disorder na nagre-recruit sa U.S.
156 pag-aaral para sa Major Depressive Disorder ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY37 pag-aaral
- Boston, MA30 pag-aaral
- Atlanta, GA24 pag-aaral
- Philadelphia, PA22 pag-aaral
- Orlando, FL19 pag-aaral
- Tampa, FL17 pag-aaral
- Miami, FL17 pag-aaral
- Chicago, IL16 pag-aaral
- Houston, TX16 pag-aaral
- San Diego, CA16 pag-aaral
- Little Rock, AR14 pag-aaral
- Austin, TX13 pag-aaral
- Orange, CA13 pag-aaral
- Glendale, CA12 pag-aaral
- Concord, CA12 pag-aaral
- Los Angeles, CA12 pag-aaral
- Las Vegas, NV12 pag-aaral
- Jacksonville, FL12 pag-aaral
- Cincinnati, OH11 pag-aaral
- Washington, DC11 pag-aaral
- Grand Prairie, TX10 pag-aaral
- Bellevue, WA9 pag-aaral
- Dallas, TX9 pag-aaral
- Newton, MA9 pag-aaral
- O'Fallon, MO9 pag-aaral
- Oceanside, CA9 pag-aaral
- Oklahoma City, OK9 pag-aaral
- Hartford, CT9 pag-aaral
- Brooklyn, NY9 pag-aaral
- San Bernardino, CA8 pag-aaral
- San Francisco, CA8 pag-aaral
- Hialeah, FL8 pag-aaral
- Columbus, OH8 pag-aaral
- Baltimore, MD8 pag-aaral
- Cleveland, OH8 pag-aaral
- Birmingham, AL8 pag-aaral
- Everett, WA8 pag-aaral
- Mountain View, CA7 pag-aaral
- Hollywood, FL7 pag-aaral
- Phoenix, AZ7 pag-aaral
Ayos sa estado
- Alabama14 pag-aaral
- Arizona12 pag-aaral
- Arkansas15 pag-aaral
- California51 pag-aaral
- Colorado10 pag-aaral
- Connecticut16 pag-aaral
- District of Columbia3 pag-aaral
- Florida31 pag-aaral
- Georgia32 pag-aaral
- Idaho3 pag-aaral
- Illinois19 pag-aaral
- Indiana4 pag-aaral
- Iowa5 pag-aaral
- Louisiana5 pag-aaral
- Maryland20 pag-aaral
- Massachusetts44 pag-aaral
- Michigan4 pag-aaral
- Minnesota7 pag-aaral
- Mississippi3 pag-aaral
- Missouri16 pag-aaral
- Nevada12 pag-aaral
- New Jersey10 pag-aaral
- New Mexico4 pag-aaral
- New York47 pag-aaral
- North Carolina12 pag-aaral
- Ohio29 pag-aaral
- Oklahoma12 pag-aaral
- Oregon5 pag-aaral
- Pennsylvania26 pag-aaral
- South Carolina8 pag-aaral
- Tennessee6 pag-aaral
- Texas37 pag-aaral
- Utah13 pag-aaral
- Virginia7 pag-aaral
- Washington20 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Precision Depression Adalimumab Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07845604Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Nagre-recruit
Edad 22 hanggang 85 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07594483Characterization and Treatment of Adolescent Depression
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 11 hanggang 25 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03388606JAK Signaling in Depression
Nagre-recruitPhase 2
Edad 25 hanggang 55 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07003997Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06793397Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06830044DBS for TRD With the Medtronic Percept PC
Nagre-recruit
Edad 25 hanggang 70 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05773755Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT03065335Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 8 hanggang 65 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT00018057The Medically Tailored Groceries and Mental Health Study
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07779707A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07105111Accelerated TMS for Perinatal Depression
Nagre-recruit
Edad 18 hanggang 55 · Kababaihan · Na-update Set 18, 2026 · NCT06968390Lumateperone for Late-Life Depression
Nagre-recruitPhase 3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07623135Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07217223Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 21 hanggang 45 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06480201Pattern Separation in Major Depressive Disorder
Nagre-recruitPhase 1
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07139834A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07284667Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06511908Leucine in Midlife Depression
Nagre-recruitPhase 2
Edad 35 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06580145Defining Neurobiological Links Between Substance Use and Mental Illness
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05538910Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.